Abstract
Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthes......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
